UBS Raises Price Target on UnitedHealth Group (UNH) Following Investor Day

November 30, 2016 9:49 AM EST
Get Alerts UNH Hot Sheet
Price: $158.49 -0.52%

Rating Summary:
    25 Buy, 2 Hold, 1 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 19 | Down: 33 | New: 11
Trade UNH Now!
Join SI Premium – FREE

Get the Pulse of the Market with StreetInsider.com's Pulse Picks. Get your Free Trial here.

UBS reiterated a Buy rating on UnitedHealth Group (NYSE: UNH), and raised the price target to $193.00 (from $180.00), following the company's investor day. UNH expects its Medicare Advantage enrollment to grow by 700-800K lives in 2017, a 19-22% Y/Y increase. UBS raised 2016 EPS estimates to $9.45 and 2017 EPS estimates to $10.70.

Analyst A.J. Rice commented, "UNH struck a very positive tone at its investor day. The 2017 adj EPS outlook of $9.30-$9.60 represents Y/Y growth of 16-20%. With respect to the Y/Y EPS tailwind, UNH highlighted roughly $0.25 tailwind from downsizing public exchanges and another $0.25 tailwind related to the HIF moratorium. The remaining $0.80-$1.10 of Y/Y EPS growth is due to the strong performance of the key underlying business. Separately, UNH expects its commercial medical cost trend of 5.5-6.5% in 2017, vs 6% in 2016."

For an analyst ratings summary and ratings history on UnitedHealth Group click here. For more ratings news on UnitedHealth Group click here.

Shares of UnitedHealth Group closed at $157.59 yesterday.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Analyst Comments, Analyst EPS Change, Analyst PT Change

Related Entities

UBS

Add Your Comment